Bacterial endocarditis masked by COVID-19: A case report

xlomafota13 shared this article with you from Inoreader Bacterial endocarditis masked by COVID-19: A case report Via Experimental and therapeutic medicine Exp Ther Med. 2022 Feb;23(2):186. doi: 10.3892/etm.2021.11109. Epub 2021 Dec 30. ABSTRACT Infective endocarditis represents a rare complication among patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); it is often a nosocomial infection and the symptomatology can be masked by respiratory failure symptoms from SARS-CoV-2 bronchopneumonia. Management of patients with severe forms of SARS-COV-2 infection who also have associated infective endocarditis is very difficult, especially in mono-specialty hospitals (such as infectious diseases hospitals) where access to cardiological investigations is limited. The current study presents the case of a 73-year-old woman with increased cardiovascular risk (high blood pressure, diabetes mellitus and obesity), with uninvestigated ischaemic heart disease, who was admitted to the Department of Infectious Diseases in the Clinical Infectious Diseases Hospital (Constanta, Romania) due to SARS-CoV-2. Although the evolution was initially favorable, the condition of the patient significantly deteriorated on the 14th day of hospitalization due to the development of Enterococcus faecium infective endocarditis. Despite the therapy, the evolution was fulminant. Infection with coronavirus disease 2019 can result in numerous comorbidities, which cause higher mortality rates than in the general population. PMID:35069867 | PMC:PMC8764899 | DOI :10.3892/etm.2021.11109 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.